Is ACTN3 useful for menopause?

The ACTN3 gene variant (R577X) is well-studied for its role in muscle fiber type – the 'power/sprint' variant (RR) vs. 'endurance' variant (XX). During menopause, muscle loss and hormonal shifts are key concerns, but there is no direct evidence linking ACTN3 to menopause outcomes or symptoms. The evidence level is unclear. A DNA test for ACTN3 might offer a clue about genetic predisposition for muscle strength, which could theoretically inform resistance training strategies in menopause – but this is speculative and not supported by menopause-specific research. MyBody-X does not market ACTN3 for menopause. For managing menopause, hormone testing, bone density scans, and lifestyle interventions are far more evidence-based. Relying on a single SNP for such a complex life stage is not recommended.